Production of monoclonal and polyclonal antibodies against human alphafetoprotein, a hepatocellular tumor marker.
The objective of this study is to produce and purify monoclonal antibodies and polyclonal antibodies (PAbs) against human alphafetoprotein (AFP). Hyperimmune ICR mice produced PAbs after injection with 0.5 mL pristane, and were injected with NS-1 myeloma cells 2 weeks later. Hyperimmune Balb/c mice were used for the production of MAbs. Mice were immunized four times, given a final boost, and their spleen cells were collected and fused with NS-1 myeloma cells under the presence of PEG 1500. The fused cells were then selected in the hypoxanthine, aminopterine, and thymidine (HAT)-RPMIX medium. Anti-AFP antibody-secreting hybridoma cell lines with high titer were cloned by enzyme-linked immunosorbent assay (ELISA) and then subcloned by limiting dilution in 15% fetal bovine serum (FBS), hypoxanthine, thymidine (HT)-RPMIX medium. Twelve murine hybridoma producing anti-AFP MAbs were obtained and designated as A73F3, A73E8, B73C5, A73G3, A73F8, 67B3, B73C2, B73E1, A73G2, B73G7, B73D7, and B73F4. Isotypes of these MAbs were identified as IgG(1) heavy chain and kappa light chain. The MAbs with high purity were obtained by affinity chromatography. The purity analysis of AFP and the MAbs was performed by capillary electrophoresis.